One of the NCI Center for Global Health's (CGH) core principles and objectives is to create mutually beneficial partnerships to improve global cancer research. NCI, together with NIH’s Fogarty International Center (FIC), engaged in exploratory discussions with many government agencies in Latin American countries. Many of the government ministries in those countries agreed to participate in the United States–Latin America Cancer Research Network (US-LA CRN).
In addition to the government agencies that participate in US-LA CRN, NCI and FIC engaged in discussions with several non-government organizations as well as domestic and international research advocacy organizations. These discussions helped forge effective partnerships to promote and enhance cancer research in Latin America.
Other NCI partners include:
American Society of Hematology and Agrupación Mexicana para el Estudio de la Hematología
In 2009, NCI partnered with the American Society of Hematology (ASH) to host an international workshop focused on clinical trial design. Currently, both NCI and ASH are partnering with ASH and the Agrupación Mexicana para el Estudio de la Hematología (AMEH) in the US-Mexico Cytogenetics Laboratory Standardization Project. The first activity of this project will be a US-Mexico Cytogenetics Laboratory Standardization Workshop on April 8, 2011 in Mexico City.
American Society of Clinical Oncology and Sociedad Latinoamericana y del Caribe de Oncología Médica
In 2011, NCI partnered with ASCO and Federación de Sociedades Latinoamericanas de Cáncerología (FLASCA) to host the second international clinical trials workshop. The goals include encouraging the development of evidence-based treatment strategies appropriate in nations with emerging economies and teaching best practices in the implementation of cancer clinical trials.
Baylor College of Medicine and Clinica las Condes (Chile)
NCI cosponsored the Santiago Breast Cancer Symposium in April 2012 with Baylor College of Medicine and Clinica las Condes (Chile) to share innovative experiences with invited health professionals, academics, students, and others interested in breast cancer. The objective of this meeting was to update best practices for beast cancer diagnosis, treatment, and monitoring. The meeting also organized study groups, brought together experts, and created opportunities for discussion and exchange of knowledge among physicians and other health professionals.